Your shopping cart is empty.

References

Health Economics: References

 

  • Appleby J, Devlin N, Parkin D (2007) NICE's cost effectiveness threshold. British Medical Journal, 25;335(7616):358-9.
     
  • Begg,D., Fischer,S., Dornbusch,R.(2003) Economics, London, McGraw-Hill
     
  • Black, W.C. (1990). The cost-effectiveness plane: a graphic representation of cost-effectiveness. Medical Decision Making, 10, 212-5
     
  • Briggs, A., Sculpher, M. and Claxton, K. (2006) Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press.
     
  • Brooks R. (1996) EuroQoL: the current state of play. Health Policy; 37:53-72
     
  • Buxton M.J., Drummond, M.F., van Hout, B., Prince, R.L., Sheldon, T.A., Szucs, T., Vray, M. (1997). Modelling in economic evaluation: an unavoidable fact of life. Health Economics, 6, 217-27.
     
  • Byford S, Torgerson DJ, Raftery J. (2000) Economic Note: Cost of illness studies. British Medical Journal 320: 1335.
     
  • Dakin, H, Devlin, N, Feng, Y, Rice, N, O'Neill, P, and Parkin, D. (2015) The Influence of Cost-Effectiveness and Other Factors on NICE Decisions. Health Economics, 24, 1256–1271. doi: 10.1002/hec.3086.
     
  • Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35(11):1095-1108.
     
  • Davis, K., Stremikis, K, Schoen, C and Squires, D. (2014) Mirror, Mirror on the Wall Update: How the U.S. Health Care System Compares Internationally. The Commonwealth Fund, June 2014.
     
  • Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L. and Torrance, G.W. (2015) Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press
     
  • Halpern, M.T., McKenna, M., Hutton, J. (1998). Modelling in economic evaluation: An unavoidable fact of life. Health Economics, 7, 741-742.
     
  • Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., Badia, X. (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10): 1727–1736. DOI: 10.1007/s11136-011-9903-x
     
  • HM Treasury (Multiple years).  The Green Book: Appraisal and Evaluation in Central Government
     
  • Hollingsworth, B., Peacock, S. (2008) Efficiency Measurement in Health and Heath Care. Routledge.
     
  • Knapp, M. (1984) The Economics of Social Care (Studies in Social Policy), Macmillan
     
  • McIntyre, D., Mooney G. (2007) The Economics of Health Equity. Cambridge University Press.
     
  • Mauskopf J., Rutten F, Schonfeld W. (2003) Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers? PharmacoEconomics, 21:991-1000
     
  • Mitton, C. Donaldson, C. (2001) Twenty-five years of programme budgeting and marginal analysis in the health sector, 1974-1999. J Health Services Research and Policy, 6:239-248
     
  • Morris, S., Devlin N., Parkin. D., Spencer, A. (2012). Economic Analysis in Health Care, 2nd Edition. London, Wiley
     
  • Murray, Christopher J L et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet , Volume 380 , Issue 9859 , 2197 - 2223
     
  • O’Donnell, O., van Doorslaer, E., Wagstaff, A., Lindelow, M. (2008) Analyzing Health Equity Using Household Survey Data. World Bank Publications.
     
  • Szende, A., Oppe, M. and Devlin, N. (Editors) (2007) EQ-5D Value Sets: Inventory, Comparative Review and User Guide, Springer Verlag.
     
  • Van Hout, B. A., Al, M. J., Gordon, G. S., et al (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Economics, 3, 309-319.

 

 

 

© David Parkin 2017